Browse

A deal with Regeneron was the last of 17 initially sought by the White House.

Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s “national priority” voucher program and will be offered to eligible patients…

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to cancers